Cargando...

Rapid Decline of OspC Borreliacidal Antibodies following Treatment of Patients with Early Lyme Disease

We determined whether the levels of OspC borreliacidal antibodies declined following treatment of early Lyme disease and whether the OspC7 peptide enzyme-linked immunosorbent assay (ELISA) could be used as an alternative test for detecting the response. Serum samples were collected from 37 subjects...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jobe, Dean A., Kowalski, Todd J., Bloemke, Marissa, Lovrich, S. D., Callister, Steven M.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2011
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3122617/
https://ncbi.nlm.nih.gov/pubmed/21508161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00063-11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!